AI-generated summary
The authors report a randomized, single-blind trial of photobiomodulation in 20 patients with burning mouth syndrome, comparing a treated group with a placebo group whose laser was turned off. The study group reported pain improvement at the end of treatment, with most remaining improved at 4 months, along with gains on some quality-of-life measures. The authors conclude the treatment seems effective for pain and psychological state.
- Participants
- 20
- Who or what was studied
- Patients with burning mouth syndrome (BMS), 10 in the photobiomodulation group and 10 in the placebo group
- Limits stated in the abstract
- The sample is small (20 patients) and the abstract does not report the wavelength used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Energy density (fluence)
- 12 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Low-level laser therapy, Visual analogue scale, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.